Tenaya Therapeutics Inc Stock News
$1.45
3.33%
today
Nasdaq,
Dec 30, 10:05 pm CET
Tenaya Therapeutics Inc Stock News
Neutral
GlobeNewsWire
●
14 days ago
Company to host conference call on Tuesday, December 17, at 8:00 a.m. ET Company to host conference call on Tuesday, December 17, at 8:00 a.m. ET
Neutral
GlobeNewsWire
●
about 2 months ago
Data Safety and Monitoring Board Endorsed Dose Escalation and Broadening of Inclusion Criteria in the MyPEAK TM -1 Phase 1b/2 Trial of TN-201 Gene Therapy
Neutral
GlobeNewsWire
●
2 months ago
Independent Data Safety and Monitoring Board Endorsed Dose Escalation and Broadening of Eligibility Criteria; Cohort 2 Now Enrolling
Neutral
GlobeNewsWire
●
4 months ago
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Tenaya's chief Executive Officer, will participate in several upcoming investment confer...
Positive
24/7 Wall Street
●
5 months ago
Penny stocks represent an interesting investment opportunity.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
